274 related articles for article (PubMed ID: 29774215)
1. Importance of Functional Loss of FUS in FTLD/ALS.
Ishigaki S; Sobue G
Front Mol Biosci; 2018; 5():44. PubMed ID: 29774215
[TBL] [Abstract][Full Text] [Related]
2. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLD spectrum diseases.
Ishigaki S; Riku Y; Fujioka Y; Endo K; Iwade N; Kawai K; Ishibashi M; Yokoi S; Katsuno M; Watanabe H; Mori K; Akagi A; Yokota O; Terada S; Kawakami I; Suzuki N; Warita H; Aoki M; Yoshida M; Sobue G
Brain; 2020 Aug; 143(8):2398-2405. PubMed ID: 32770214
[TBL] [Abstract][Full Text] [Related]
3. The
Yokoi S; Ito T; Sahashi K; Nakatochi M; Nakamura R; Tohnai G; Fujioka Y; Ishigaki S; Udagawa T; Izumi Y; Morita M; Kano O; Oda M; Sone T; Okano H; Atsuta N; Katsuno M; Okada Y; Sobue G
J Neurosci; 2022 Nov; 42(47):8881-8896. PubMed ID: 36261283
[TBL] [Abstract][Full Text] [Related]
4. Altered Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes.
Ishigaki S; Fujioka Y; Okada Y; Riku Y; Udagawa T; Honda D; Yokoi S; Endo K; Ikenaka K; Takagi S; Iguchi Y; Sahara N; Takashima A; Okano H; Yoshida M; Warita H; Aoki M; Watanabe H; Okado H; Katsuno M; Sobue G
Cell Rep; 2017 Jan; 18(5):1118-1131. PubMed ID: 28147269
[TBL] [Abstract][Full Text] [Related]
5. [Aberrant Interaction Between FUS and SFPQ in Neurons in a Wide Range of FTLD Spectrum Diseases].
Ishigaki S
Brain Nerve; 2021 Sep; 73(9):1021-1028. PubMed ID: 34462374
[TBL] [Abstract][Full Text] [Related]
6. 3'UTR Length-Dependent Control of SynGAP Isoform α2 mRNA by FUS and ELAV-like Proteins Promotes Dendritic Spine Maturation and Cognitive Function.
Yokoi S; Udagawa T; Fujioka Y; Honda D; Okado H; Watanabe H; Katsuno M; Ishigaki S; Sobue G
Cell Rep; 2017 Sep; 20(13):3071-3084. PubMed ID: 28954225
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of Frontotemporal Lobar Degeneration: Insights From Loss of Function Theory and Early Involvement of the Caudate Nucleus.
Sobue G; Ishigaki S; Watanabe H
Front Neurosci; 2018; 12():473. PubMed ID: 30050404
[TBL] [Abstract][Full Text] [Related]
8. FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD.
Orozco D; Edbauer D
J Mol Med (Berl); 2013 Dec; 91(12):1343-54. PubMed ID: 23974990
[TBL] [Abstract][Full Text] [Related]
9. FUS regulates AMPA receptor function and FTLD/ALS-associated behaviour via GluA1 mRNA stabilization.
Udagawa T; Fujioka Y; Tanaka M; Honda D; Yokoi S; Riku Y; Ibi D; Nagai T; Yamada K; Watanabe H; Katsuno M; Inada T; Ohno K; Sokabe M; Okado H; Ishigaki S; Sobue G
Nat Commun; 2015 May; 6():7098. PubMed ID: 25968143
[TBL] [Abstract][Full Text] [Related]
10. The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons.
Honda D; Ishigaki S; Iguchi Y; Fujioka Y; Udagawa T; Masuda A; Ohno K; Katsuno M; Sobue G
FEBS Open Bio; 2013; 4():1-10. PubMed ID: 24319651
[TBL] [Abstract][Full Text] [Related]
11. FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD.
Fujioka Y; Ishigaki S; Masuda A; Iguchi Y; Udagawa T; Watanabe H; Katsuno M; Ohno K; Sobue G
Sci Rep; 2013; 3():2388. PubMed ID: 23925123
[TBL] [Abstract][Full Text] [Related]
12. Loss of fused in sarcoma (FUS) promotes pathological Tau splicing.
Orozco D; Tahirovic S; Rentzsch K; Schwenk BM; Haass C; Edbauer D
EMBO Rep; 2012 Aug; 13(8):759-64. PubMed ID: 22710833
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of nuclear FUS induces neuronal cell death.
Suzuki H; Matsuoka M
Neuroscience; 2015 Feb; 287():113-24. PubMed ID: 25497700
[TBL] [Abstract][Full Text] [Related]
14. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
[TBL] [Abstract][Full Text] [Related]
15. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
Neumann M
Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
[TBL] [Abstract][Full Text] [Related]
16. Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS.
Suárez-Calvet M; Neumann M; Arzberger T; Abou-Ajram C; Funk E; Hartmann H; Edbauer D; Kremmer E; Göbl C; Resch M; Bourgeois B; Madl T; Reber S; Jutzi D; Ruepp MD; Mackenzie IR; Ansorge O; Dormann D; Haass C
Acta Neuropathol; 2016 Apr; 131(4):587-604. PubMed ID: 26895297
[TBL] [Abstract][Full Text] [Related]
17. Altered mRNP granule dynamics in FTLD pathogenesis.
Bowden HA; Dormann D
J Neurochem; 2016 Aug; 138 Suppl 1():112-33. PubMed ID: 26938019
[TBL] [Abstract][Full Text] [Related]
18. [Conjoint pathological cascades mediated by RNA-binding proteins, TDP-43, FUS and ataxin-2].
Ito D
Rinsho Shinkeigaku; 2012; 52(11):1221-3. PubMed ID: 23196570
[TBL] [Abstract][Full Text] [Related]
19. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
Baloh RH
Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
[TBL] [Abstract][Full Text] [Related]
20. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis.
Mackenzie IR; Neumann M
Brain Res; 2012 Jun; 1462():40-3. PubMed ID: 22261247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]